Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. (Q54632312)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. |
scientific article |
Statements
Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. (English)
1 reference
Cheng-Xi Zhang
1 reference
Si-Nian Pan
1 reference
Rong-Sen Meng
1 reference
Chao-Quan Peng
1 reference
Zhao-Jun Xiong
1 reference
Bao-Lin Chen
1 reference
Guang-Qin Chen
1 reference
Feng-Juan Yao
1 reference
Yi-Li Chen
1 reference
Yue-Dong Ma
1 reference
Yu-Gang Dong
1 reference
1 January 2011
1 reference
38
1 reference
1
1 reference
55-62
1 reference
Identifiers
1 reference